Assignee
THERAVECTYS
FR·6 granted patents·6 pending applications·14 citations·filing 2012–2022
Top patents by PatentIndex Score
12 records- 0184US10752668B2Lentiviral vectors for regulated expression of a chimeric antigen receptor moleculeTHERAVECTYS·Filed 2015·Granted Aug 25, 2020·8 cites·5 claims
- 0282US9657311B2Lentiviral vectors containing an MHC class I, MHC class II, or B2 microglobulin upstream promoter sequenceTHERAVECTYS·Filed 2014·Granted May 23, 2017·5 cites·21 claims
- 0365US8951535B2Lentiviral vectors containing an MHC class I promoterTHERAVECTYS·Filed 2013·Granted Feb 10, 2015·1 cites·19 claims
- 0459US2025073332A1Lentiviral vector, lentiviral particle for treating hepatitis b and its preparation method and application thereofTHERAVECTYS·Filed 2022·Application pending·0 cites
- 0557US2024415951A1Lentiviral vector for expression of human papillomavirus (hpv) antigens and its implementation in the treatment of hpv induced cancersTHERAVECTYS·Filed 2022·Application pending·0 cites
- 0654US2024053339A1High throughput methods and products for sars-cov-2 sero-neutralization assayTHERAVECTYS·Filed 2021·Application pending·0 cites
- 0750US2021009653A1Lentiviral vectors for regulated expression of a chimeric antigen receptor moleculeTHERAVECTYS·Filed 2020·Application pending·0 cites
- 0848US9752160B2Use of non-subtype B gag proteins for lentiviral packagingTHERAVECTYS·Filed 2012·Granted Sep 5, 2017·0 cites·13 claims
- 0947US2017362607A1Use of non-subtype b gag proteins for lentiviral packagingTHERAVECTYS·Filed 2017·Application pending·0 cites
- 1046US2015182617A1Glycoproteins for pseudotyping lentivectorsTHERAVECTYS·Filed 2013·Application pending·0 cites
- 1141US10864265B2Lentiviral vectors for expression of hepatitis B virus (HBV) antigensTHERAVECTYS·Filed 2017·Granted Dec 15, 2020·0 cites·17 claims
- 1230US9987351B2Lentiviral vectors for generating immune responses against human T Lymphotrophic Virus Type 1THERAVECTYS·Filed 2015·Granted Jun 5, 2018·0 cites·12 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →